p73 is a human p53-related protein that can induce apoptosis

被引:889
作者
Jost, CA
Marin, MC
Kaelin, WG
机构
[1] DANA FARBER CANC INST,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,BOSTON,MA 02115
关键词
D O I
10.1038/38298
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The protein p53 is the most frequently mutated tumour suppressor to be identified so far in human cancers(1,2). The ability of p53 to inhibit cell growth is due, at least in part, to its ability to bind to specific DNA sequences and activate the transcription of target genes such as that encoding the cell-cycle inhibitor p21(Waf1/Cip1) (ref. 3), A gene has recently been identified that is predicted to encode a protein with significant amino-acid sequence similarity to p53 (ref, 4), In particular, each of the p53 amino-acid residues implicated in direct sequence-specific DNA binding is conserved in this protein(5). This gene, called p73, maps to the short arm of chromosome 1, and is found in a region that is frequently deleted in neuroblastomas(6). Here we show that p73 can, at least when overproduced, activate the transcription of p53-responsive genes and inhibit cell growth in a p53-like manner by inducing apoptosis (programmed cell death).
引用
收藏
页码:191 / 194
页数:4
相关论文
共 26 条
  • [1] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915
  • [2] ALLELIC LOSS OF CHROMOSOME-1P36 IN NEUROBLASTOMA IS OF PREFERENTIAL MATERNAL ORIGIN AND CORRELATES WITH N-MYC AMPLIFICATION
    CARON, H
    VANSLUIS, P
    VANHOEVE, M
    DEKRAKER, J
    BRAS, J
    SLATER, R
    MANNENS, M
    VOUTE, PA
    WESTERVELD, A
    VERSTEEG, R
    [J]. NATURE GENETICS, 1993, 4 (02) : 187 - 190
  • [3] HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA
    CHEN, C
    OKAYAMA, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) : 2745 - 2752
  • [4] CHEN XB, 1993, GENE DEV, V7, P2652
  • [5] COOPERATIVE DNA-BINDING OF P53 WITH TFIID (TBP) - A POSSIBLE MECHANISM FOR TRANSCRIPTIONAL ACTIVATION
    CHEN, XB
    FARMER, G
    ZHU, H
    PRYWES, R
    PRIVES, C
    [J]. GENES & DEVELOPMENT, 1993, 7 (10) : 1837 - 1849
  • [6] CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS
    CHO, YJ
    GORINA, S
    JEFFREY, PD
    PAVLETICH, NP
    [J]. SCIENCE, 1994, 265 (5170) : 346 - 355
  • [7] P53 FUNCTIONS AS A CELL-CYCLE CONTROL PROTEIN IN OSTEOSARCOMAS
    DILLER, L
    KASSEL, J
    NELSON, CE
    GRYKA, MA
    LITWAK, G
    GEBHARDT, M
    BRESSAC, B
    OZTURK, M
    BAKER, SJ
    VOGELSTEIN, B
    FRIEND, SH
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (11) : 5772 - 5781
  • [8] DILLER L, 1995, CANCER RES, V55, P2910
  • [9] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [10] DNA-BINDING-DEFECTIVE MUTANTS OF THE EPSTEIN-BARR-VIRUS LYTIC SWITCH ACTIVATOR ZTA TRANSACTIVATE WITH ALTERED SPECIFICITIES
    FLEMINGTON, EK
    LYTLE, JP
    CAYROL, C
    BORRAS, AM
    SPECK, SH
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (05) : 3041 - 3052